# Galantamine Versus Placebo in Childhood Autism

> **NCT00252603** · PHASE3 · COMPLETED · sponsor: **University of Medicine and Dentistry of New Jersey** · enrollment: 20 (—)

## Conditions studied

- Autism
- Childhood Autism

## Interventions

- **DRUG:** Galantamine

## Key facts

- **NCT ID:** NCT00252603
- **Lead sponsor:** University of Medicine and Dentistry of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2007-04
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00252603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00252603, "Galantamine Versus Placebo in Childhood Autism". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00252603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*